Search CommunityWalk:
Create_a_map_small
Mymaps_small



Blank

VIRxSYS Corporation

Address:
200 Perry Parkway, Suite 1A
--
Gaithersburg, MD, USA
1-301-987-0480

Category: Drug Delivery

Used in the following map:

Maryland Biotech Industry Map

VIRxSYS Corporation is a biotechnology company focused on the use of proprietary lentiviral vector delivery and RNA payload platforms to develop therapies for serious human diseases. The company was founded in 1998 with a mission to become the recognized leader in RNA based medicines and vaccines to treat serious human diseases.

VIRxSYS Corporation's technology platforms include: SMaRT(TM) RNA Platform, Lentiviral vector platform. Its Spliceosome-Mediated RNA Trans-splicing (SMaRT(TM) RNA) is a novel, fully-patented, and versatile RNA technology used for multiple disease indications. This proprietary technology is capable of repairing and re-programming genes at the RNA level to produce a totally different protein of therapeutic interest, such as diverting plasma albumin production in the liver toward apolipoprotein A-I (apoA-I), factor VIII, or even small antibody fragments. Its SMaRT(TM) RNA Platform can also be used for second generation antibody production (in vivo antibody manufacturing), real-time molecular imaging, genomics and molecular evolution, and induced pluripotent stem cells (iPS cells) generation.

VIRxSYS Corporation has developed lentiviral vector technology platform for RNA molecule delivery. This vector platform is based on the lentivirus (LV) class of virus which has remarkable properties for safe, efficient, predictable, and sustained delivery of payloads into cells. The company's vector delivery platform is used in therapies against viral infections, genetic disorders, cardiovascular diseases and others. Its product pipeline includes: VRX496(TM) indicated for the treatment against HIV, VRX1243 indicated for the treatment of cardiovascular disease, VRX1273 indicated as a vaccine against HIV, etc.

VIRxSYS Corporation has collaborations with Duke University Medical Center, Johns Hopkins University, Harvard Medical School, National Cancer Institute, Stanford University, University of Barcelona, University of Iowa, University of Pennsylvania, etc.